AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
Log in

NASDAQ:PHASPhaseBio Pharmaceuticals Earnings Date, Estimates & History

$4.55
+0.16 (+3.64 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.17
Now: $4.55▼
$4.63
50-Day Range
$4.25
MA: $4.87▼
$6.02
52-Week Range
$2.60
Now: $4.55▼
$12.95
Volume245,170 shs
Average Volume565,740 shs
Market Capitalization$130.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.93

Earnings

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Earnings Information

PhaseBio Pharmaceuticals last released its earnings data on May 12th, 2020. The reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.42) by $0.10. The business earned $0.32 million during the quarter, compared to the consensus estimate of $0.38 million. PhaseBio Pharmaceuticals has generated ($1.43) earnings per share over the last year. PhaseBio Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2020 based off prior year's report dates.

PhaseBio Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Earnings Estimates

2020 EPS Consensus Estimate: ($2.09)
2021 EPS Consensus Estimate: ($2.41)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.48)($0.48)($0.48)
Q2 20201($0.52)($0.52)($0.52)
Q3 20201($0.53)($0.53)($0.53)
Q4 20201($0.56)($0.56)($0.56)
Q1 20211($0.59)($0.59)($0.59)
Q2 20211($0.63)($0.63)($0.63)
Q3 20211($0.57)($0.57)($0.57)
Q4 20211($0.62)($0.62)($0.62)

PhaseBio Pharmaceuticals (NASDAQ PHAS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/11/2020
(Estimated)		       
5/12/2020Q1 2020($0.4220)($0.52)($0.52)$0.38 million$0.32 millionN/A
3/30/202012/31/2019($0.40)($0.39)($0.39)$0.40 million$0.76 millionN/A
11/14/2019Q3($0.36)($0.40)($0.40)$0.35 million$0.24 millionN/A
8/13/2019Q2 2019($0.35)($0.3305)($0.33)$0.13 million$0.70 millionN/A
5/9/20193/31/2019($0.44)($0.30)($0.30)$0.12 million$0.65 millionN/A
3/26/201912/31/2018($0.29)($0.26)($0.26)$0.26 millionN/A
11/29/2018Q3($0.22)($10.45)($10.45)$0.41 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.